Access to Medicines Program
E853090
The Access to Medicines Program is a Public Citizen initiative that advocates for affordable, equitable access to essential medicines worldwide by challenging high drug prices and restrictive pharmaceutical policies.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Access to Medicines Program canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T10268729 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Access to Medicines Program Context triple: [Public Citizen, hasOrganizationalUnit, Access to Medicines Program]
-
A.
340B Drug Pricing Program
The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
-
B.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
C.
Therapeutics for Rare and Neglected Diseases program
The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.
-
D.
Partners In Health
Partners In Health is a global health and social justice organization that delivers high-quality medical care to impoverished communities around the world and advocates for equitable health systems.
-
E.
Medicaid Drug Rebate Program
The Medicaid Drug Rebate Program is a U.S. federal initiative that requires drug manufacturers to provide rebates to state Medicaid programs in exchange for Medicaid coverage of their outpatient prescription drugs, helping control costs for the program.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Access to Medicines Program Target entity description: The Access to Medicines Program is a Public Citizen initiative that advocates for affordable, equitable access to essential medicines worldwide by challenging high drug prices and restrictive pharmaceutical policies.
-
A.
340B Drug Pricing Program
The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
-
B.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
C.
Therapeutics for Rare and Neglected Diseases program
The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.
-
D.
Partners In Health
Partners In Health is a global health and social justice organization that delivers high-quality medical care to impoverished communities around the world and advocates for equitable health systems.
-
E.
Medicaid Drug Rebate Program
The Medicaid Drug Rebate Program is a U.S. federal initiative that requires drug manufacturers to provide rebates to state Medicaid programs in exchange for Medicaid coverage of their outpatient prescription drugs, helping control costs for the program.
- F. None of above. chosen
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
advocacy program
ⓘ
health policy initiative ⓘ |
| advocatesFor |
affordable medicines
ⓘ
conditions on public funding to ensure affordable access ⓘ equitable access to essential medicines ⓘ expanded use of TRIPS flexibilities for public health ⓘ strong government negotiation of drug prices ⓘ strong public health safeguards in trade agreements ⓘ |
| affiliatedWith |
Public Citizen Health Research Group
ⓘ
linked to:
Public Citizen Foundation
|
| aimsTo |
ensure that publicly funded research leads to affordable products
ⓘ
increase transparency in drug pricing and R&D costs ⓘ promote generic and biosimilar competition ⓘ reduce barriers to access to essential medicines ⓘ |
| areaOfWork |
access to medicines
ⓘ
drug pricing ⓘ global health ⓘ pharmaceutical policy ⓘ |
| benefits |
patients
ⓘ
public health systems ⓘ |
| countryOfOperation |
United States
ⓘ
linked to:
United States of America
|
| focusesOn |
biologic and biosimilar competition
ⓘ
generic competition ⓘ high drug prices ⓘ intellectual property and medicines ⓘ pharmaceutical transparency ⓘ public funding of medical research ⓘ |
| languageOfWork | English ⓘ |
| mission |
to challenge high drug prices and restrictive pharmaceutical policies
ⓘ
to promote affordable access to essential medicines worldwide ⓘ |
| nonProfitStatus | nonprofit initiative ⓘ |
| opposes |
excessive pharmaceutical monopolies
ⓘ
patent evergreening ⓘ trade rules that restrict access to generic medicines ⓘ |
| parentOrganizationType | consumer advocacy organization ⓘ |
| partOf | Public Citizen ⓘ |
| scaleOfActivity | global ⓘ |
| topic |
TRIPS and trade-related intellectual property rules
ⓘ
essential medicines ⓘ global health equity ⓘ medicine pricing regulation ⓘ pharmaceutical patents ⓘ |
| usesStrategy |
coalition building
ⓘ
legal and regulatory interventions ⓘ policy advocacy ⓘ public education ⓘ research and publication of policy analyses ⓘ |
| website | https://www.citizen.org ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Access to Medicines Program Description of subject: The Access to Medicines Program is a Public Citizen initiative that advocates for affordable, equitable access to essential medicines worldwide by challenging high drug prices and restrictive pharmaceutical policies.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.